moray

About Moray Wright

Moray is CEO of Parkwalk, which he co-founded in 2009.

12 October 2018

Oxbotica – appoints Fraser Robinson to drive global strategy

By |October 12th, 2018|

Oxbotica, the autonomous software company, today announces the appointment of Fraser Robinson to its board of directors. This follows Oxbotica’s recent completion of a £14 million investment which will support the next stage of its international development.

Robinson comes with a rare and proven track record, most recently leading Uber’s investment negotiations, strategy and partnerships […]

Vitamica – University of Bristol Enterprise Fund II investment

By |October 9th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Vitamica, a University of Bristol spin-out that aims to exploit a novel approach for determining the susceptibility of bacteria to antibiotics.

Resistance of bacteria to antibiotics is an increasing problem across the world, resulting in poorer healthcare […]

27 September 2018

Healthera – UCEF V investment

By |September 27th, 2018|

We are delighted to announce that the University of Cambridge Enterprise Fund V has invested in a £3m Series A financing round into Healthera, a provider of next-generation, pharmacy-integrated personal health management solutions.

Healthera connects patients to a platform of hundreds of pharmacies and NHS GPs, allowing them to order and track prescriptions, access clinical […]

Oxbotica – Parkwalk investment

By |September 19th, 2018|

Oxbotica, the autonomous vehicle software company, today announces the completion of a £14 million investment to support the next stage of its growth strategy. Funds have been secured from three leading investors: IP Group plc, Parkwalk Advisors and AXA XL (formerly XL Catlin).

The investment will be used to further accelerate Oxbotica’s sustained growth, which […]

AudioTelligence – University of Cambridge Enterprise Fund V investment

By |September 18th, 2018|

We have recently made an investment in a £3.1m seed funding round in to AudioTelligence for the University of Cambridge Enterprise Fund V.

AudioTelligence is delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.

Speech control is being used increasingly in consumer electronics, with smart speakers being the world’s fastest-growing consumer […]

Lettus Grow – University of Bristol Enterprise Fund II investment

By |September 1st, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Lettus Grow.

Lettus Grow is a Bristol-based company supported by the award winning SETSquared incubator and the Oracle Global Cloud Accelerator. The company has developed a novel irrigation system to increase productivity in food production, with early […]

10 August 2018

Astellas announces acquisition of Quethera

By |August 10th, 2018|

Astellas Pharma Inc. and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom that is focused on developing novel treatments for ocular disorders, such as glaucoma.

Through this transaction, Astellas has acquired Quethera’s ophthalmic gene therapy program, which uses a recombinant adeno-associated viral vector system (rAAV) to introduce […]

University of Cambridge Enterprise Fund VI launched

By |August 3rd, 2018|

Parkwalk are delighted to announce the launch of the University of Cambridge Enterprise Fund VI.

Launched in conjunction with Cambridge Enterprise, the University’s Technology Transfer and academic consulting subsidiary, the University of Cambridge Enterprise Funds offer alumni and investors the opportunity to invest in companies formed to develop and commercialise technology and intellectual property developed at the University of Cambridge in […]

Ilika – Parkwalk investment

By |August 1st, 2018|

We are delighted to announce that the Parkwalk Opportunities EIS Fund has participated in a £4.4m funding round in Ilika, an AIM listed company which specialises in materials innovation. The company has developed unique solid state battery technology which may have applications across the Internet of Things (IoT).

Ilika spun out of the University of […]

20 July 2018

Bramble Energy – Parkwalk investment

By |July 20th, 2018|

We have recently closed an investment in Bramble Energy , a UCL and Imperial College London spinout which has developed a unique, patent protected, printed circuit board (PCB) fuel cell – the PCBFC™.

The PCBFC™ utilises cost-effective production methods and materials from the PCB industry to reduce the cost and complexity of manufacturing of proton exchange […]

Undo – Parkwalk investment

By |July 13th, 2018|

We have recently closed an investment in Undo, a Cambridge company whose products transform the way organisations handle software quality issues. Undo helps improve customers’ software quality and productivity, enabling them to fix their ‘unfixable’ bugs, and offers huge improvements in development productivity.

Undo offers a new way of diagnosing and fixing Linux C/C++ application failures […]

23 June 2018

Microsaic Systems – Parkwalk closes follow on investment

By |June 23rd, 2018|

We are delighted to have participated in a placing for Microsaic Systems:
22 June 2018 Microsaic Systems plc (“Microsaic”, “Microsaic Systems” or the “Company”)
Result of General Meeting, Completion of Fundraising and Total Voting Rights
Microsaic Systems plc (AIM: MSYS), the developer of point of need mass spectrometry (“MS”) instruments , is pleased to announce that, at its General Meeting held […]

30 May 2018

Opsydia unveils ground-breaking new technology

By |May 30th, 2018|

Laser marking by University of Oxford spinout transforms diamond security

Opsydia, a spinout from the University of Oxford, has unveiled ground-breaking new technology that will help address the risk of tampering and counterfeiting in the diamond sector.

Using high precision lasers, Opsydia can make tiny marks, less than 1/50th of the size of a human hair, […]

RoadMap – University of Cambridge Enterprise Fund V investment

By |May 16th, 2018|

We have recently made an investment in RoadMap for the University of Cambridge Enterprise Fund V in a Series ‘B’ financing.

RoadMap is founded on four patents licensed from the Cambridge Centre for Advanced Photonics and Electronics (CAPE) in the area of silicon wavelength switch technology.

Network operators are facing the triple challenge of increasing capacity to […]

Salunda – Parkwalk follow-on Investment

By |May 1st, 2018|

We are pleased to announce that the Parkwalk Opportunities Fund and the University of Oxford Innovation Fund IV have participated in a second investment in Salunda Limited, originally a University of Oxford spin-out, and provider of specialist ‘smart systems’ for monitoring equipment and fluids.
The company is successfully targeting safety critical applications for oilfield drilling, […]

15 April 2018

Sorex Sensors – UCEF V investment

By |April 15th, 2018|

We have recently closed an investment in Sorex Sensors for the University of Cambridge Enterprise Fund V.

Sorex Sensors is a spin‐out from the Department of Electrical Engineering at the University of Cambridge. The company has developed a dual-mode film bulk acoustic resonator (FBAR) sensor technology.

The devices, fabricated on a silicon wafer, comprise a thin film […]

26 March 2018

Cambridge Touch Technologies – UCEF V and Opportunities Fund investment

By |March 26th, 2018|

We have recently closed an investment in Cambridge Touch Technologies for the University of Cambridge Enterprise Fund V and the Parkwalk Opportunities Fund.

CTT spun-out of the Centre for Advanced Photonics and Engineering (CAPE) at the University of Cambridge. The technology has been developed in collaboration with the laboratory of Professor Arokia Nathan with whom the […]

MediaGamma – Parkwalk closes Investment

By |March 15th, 2018|

We are delighted to announce that Parkwalk and the UCL Technology Fund have co-led a £2m funding of MediaGamma, a UCL Business spin-out developing  predictive analytics software.

The company has developed a world leading enterprise-grade reinforcement machine learning (self-learning) platform, delivering decisions in under five milliseconds. It has proven its technology in programmatic advertising, building and training […]

Brainomix – Parkwalk closes follow-on investment

By |March 7th, 2018|

We have recently closed an investment in Brainomix for the Parkwalk Opportunities EIS Fund and the University of Oxford Innovation Fund IV.

Brainomix, the medical imaging company using artificial intelligence (AI) for the fast diagnosis and treatment of stroke victims, has closed a £7m ($9.8m) funding roundt to bring its software to the global healthcare market.

Parkwalk lead […]

7 February 2018

Parkwalk wins at EISA Awards

By |February 7th, 2018|

Parkwalk are delighted to have won the ‘Best EIS Fund Manager’ category at the EISA awards on the 6th February 2018 at the House of Lords.

The award recognised an extremely strong 2017 for Parkwalk, where we committed in excess of £75m to hard-science, knowledge-intensive growth companies commercialising the best of British innovation spun-out of […]